Save hours of research by dissecting Immune-Oncology (IO) clinical trial data on our trends dashboard. It helps you visualize data of ~7,000 IO clinical trials while filtering real-time data across manually verified and structured biological variables.
Get an executive view to compare IO clinical trials across therapies, indications, sponsors, and targets. You can even look at overlaps and list unique entities related to clinical trials across each of these.
Inform and expedite the process of building your next clinical trial protocol by understanding eligibility criteria of other protocols. You can also discover the most common inclusions and exclusions by phase, therapeutic area, and several other parameters.
Navigate the complex landscape of combinations for immuno-oncology therapies, explore the most frequent combinations used for a disease of your interest.
Receive bespoke reports and custom services, among other forms of support, based on your searches on IOClinica.
Identify and prioritize the right tumor type by using a combination of proprietary algorithms to correlate disease biology, drug response, and pathway analysis in different tumor types.LEARN MORE
Fast track the approval of your asset and decrease patient burden by identifying the subset of disease as well as the treatment that is most likely to work.LEARN MORE
The process of overcoming the limitations of monotherapy is often elaborate and expensive. With IO services, you can now explore and identify effective drug combinations for different cancer types.LEARN MORE
Current drug discovery efforts are mainly focused on previously validated 'druggable’ protein families. However, our computational pipelines expand and diversify this portfolio by identifying and validating new cancer-relevant targets.LEARN MORE
Single-cell RNA-seq is a powerful tool for revealing heterogeneity in cancer cells. We have built pipelines that classify individual tumor cells, and study interactions between malignant cells and immune cells in the tumor microenvironmentLEARN MORE